
News|Articles|December 9, 2024
Recap Key Industry Trends for Viral Clearance and NGS
Author(s)Charles River
Learn highlights from the 2024 event, including new strategies for viral clearance and NGS applications for viral safety testing.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
2
Charles River Incubator Cohort to Accelerate CGT Development
3
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
4
FAQ: Shifts in FDA Regulations and Strategies in 2025
5
